Skip to content

Periwalking for labor analgesia. Comparative study between two anesthetics

Epidural Block with Ultra-low doses of Local anesthetics (Periwalking) for Labor analgesia. Comparative study between 2 anesthetics

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-84gy8sc
Enrollment
Unknown
Registered
2024-12-03
Start date
2024-12-18
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Conduction

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 38 women undergoing epidurals with a low dose of ropivacaine associated with fentanyl. Control group: 38 wome

Sponsors

Hospital da Mulher Professor Doutor José Aristodemo Pinotti
Lead Sponsor
Hospital da Mulher Professor Doutor José Aristodemo Pinotti
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Primiparas on active labor; patients classified as ASA 2 in accordance with the American Society of Anesthesiologists class 2; AGE higher than 18 yo; higher than 37 weeks of gestational age; single, live fetus with cephalic position; cervical dilation higher or equal than 6 cm; without previous cesarian section

Exclusion criteria

Exclusion criteria: Regional anesthesia contra-indication; alergic reactions with local anesthetics;ASA3 or more; psychiatry disorders; drugadiction; age below 18yo; Body mass index 40; fetus malformation

Design outcomes

Primary

MeasureTime frame
It is supposed to evidence a mean diference of 3 points on the quality of analgesia measured by numeric pain scale (NPS= 0 to 10).

Secondary

MeasureTime frame
Quality of analgesia in 1 hour, 2 hours and up to delivery period.

Countries

Brazil

Contacts

Public ContactVanessa Carvalho

Faculdade de ciências médicas da universidade estadual de campinas

vanessah@unicamp.br+55(19)3521-9560

Outcome results

None listed

Source: REBEC (via WHO ICTRP)